• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . A structural and mechanistic atlas of NTD antibody neutralization and immune escape across SARS-CoV-2 prototype and its

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2026 Aug 11;123(32):e2535385123.
doi: 10.1073/pnas.2535385123. Epub 2026 Aug 5.
A structural and mechanistic atlas of NTD antibody neutralization and immune escape across SARS-CoV-2 prototype and its (sub-)variants

Jianjie Zhou[SUP] #[/SUP][SUP] 1 [/SUP], Wenyu Li[SUP] #[/SUP][SUP] 1 2 [/SUP], Xiaoyun Wang[SUP] #[/SUP][SUP] 1 3 [/SUP], Junqing Sun[SUP] 1 [/SUP], Shuxin Guo[SUP] 4 5 [/SUP], Xiaoyu Rong[SUP] 1 [/SUP], Zhou Tong[SUP] 1 [/SUP], Lianpan Dai[SUP] 1 [/SUP], William Jun Liu[SUP] 6 [/SUP], Jianxun Qi[SUP] 1 3 [/SUP], George Fu Gao[SUP] 1 4 6 [/SUP], Qihui Wang[SUP] 1 3 [/SUP]


Affiliations
Abstract

The N-terminal domain (NTD) of the SARS-CoV-2 spike (S) is a critical antibody target, yet its epitope organization, neutralization mechanisms, and immune evasion strategies remain incompletely resolved. Here, we classify NTD antibodies into nine spatially distinct classes (designated as NTD-1 to NTD-9), including a cryptic epitope defined here (NTD-8). Mechanistic studies reveal that NTD-5 and NTD-9 antibodies neutralize by inducing S1 shedding, thereby extending this mechanism to selected NTD-directed antibodies. Format profiling shows that while most NTD antibodies require bivalency, selected antibodies from NTD-3, NTD-5, and NTD-9 retain neutralizing activity in Fab form. Profiling 41 antibodies across prototype, Delta, and 17 Omicron subvariants defines an epitope-resolved escape landscape and enables dissection of three convergent evasion strategies: contact residue disruption, glycan shielding, and conformational remodeling. Notably, the KP.3.1.1 subvariant uses a dual escape mechanism in which ∆S31 introduces N30 glycosylation and substantially remodels the S27-R34 region, undermining recognition by both NTD-5 and NTD-9 antibodies. These findings provide a structural and mechanistic framework for rational vaccine and antibody design resilient to antigenic drift.

Keywords: N-terminal domain; NTD antibody epitope classification; SARS-CoV-2; immune escape; neutralization mechanism.

 
Back
Top